Picture of Kalvista Pharmaceuticals logo

KALV — Kalvista Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Brief: Kalvista Pharmaceuticals Q2 Net Income USD -42.268 Million

Dec 05 (Reuters) - Kalvista Pharmaceuticals Q2 basic EPS USD -0.91.
* Q2 operating expenses USD 45.811 million
* Q2 operating income USD -45.811 million

Recent news on Kalvista Pharmaceuticals

See all news